StockAnalyzer

Financial Analysis

DashboardSectorsComparablesScreenerUniverseMicrocapsAI 2nd OrderTheme MapEnergy & MaterialsMacroWatchlistCompareMi CarteraPortfolio

Recent

v0.1
NATURAL.BO$3.49-0.57%
Fair $3.49+0.0%

NATURAL.BO

Natural Biocon (India) Limited

Basic Materials / Specialty ChemicalsBSE

$3.49

-0.02 (-0.57%)

Fairly Valued+0.0%Fair Value $3.49Fund rank 28/100 · Data gapFallback financials|
SA 23/D
F-Score: 3/9
Declining RevenueMargin CompressionLow Profitability

FCF base 3Y

n/d

n/d CAGR · yield n/d

FCF base 5Y

n/d

n/d base · n/d expected

Precio de entrada

n/d

MOS 34% · confianza 19%

FCF escenarios

weak_data · normalized FCF $123000.00 · quality 48.7/100

Data gap 28/100
Bear 5Yn/dn/d
Base 5Yn/dn/d
Bull 5Yn/dn/d
Return 0/100Downside 20/100Model quality 20/100Data QA 20/100

Ranking barato/determinista: CAGR esperado 5Y + downside bear + calidad del modelo + balance + capital allocation + data gate. No entra en buy-candidate si la data es débil o el CAGR 5Y no compensa.

Quality + valuation scorecard

SA Score

23/100

D

Piotroski

3/9

balance/quality

Valuation

50/100

+0.0% upside

5Y CAGR

+0.0%

50/100

Data QA

16/100

SEC 0%

Latest source: unknownPeriods: 4Warnings: 3unknown: 4
No SEC-backed annual rows; valuation uses fallback financial data. Sector-specific commodity mid-cycle model required: targets are disabled until normalized cycle price/cost-curve/reserve data exists. Revenue has declined for 2 consecutive years Operating margin has declined for 3 consecutive years ROE is -0.1%, below the 5% threshold
Thesis & Journal · NATURAL.BOLocal privado en este navegador · Natural Biocon (India) Limited
Plantilla tipo buy-side: tesis, bull/base/bear, catalizadores, riesgos, kill criteria y fecha de revisión. Esto no gasta GPT-5.5; luego lo usamos como contexto del memo.

Sin guardar todavía.

Market Cap

$90M

P/E

N/A

•

EV/EBITDA

N/A

•

ROE

-0.1%

↑

Gross Margin

14.5%

↓

Debt/Equity

0.01

↓
52-Week Range$3
$3$16

TradingView lightweight chart

NATURAL.BO price, volumen y niveles de valoración

Último $3.460Periodo -72.3%
Fair value: $3.490

Price & Ratios

Absolute Values (Left Axis)

Ratios / Percentages (Right Axis)

Financial statement dashboard

Crecimiento, márgenes y provenance

2023–2026 · 3 años de histórico normalizado

Revenue CAGR

+26.6%

FCF CAGR

-61.2%

FCF margin

0.5%

FCF / Net income

-0.31x

Latest source

Provider fallback

Margin decomposition

Último año: revenue $25.4M · net income $-400000.0 · FCF $123000.0

2023-FY → 2026-FY

Gross margin

14.5%-15.4% pts

Operating margin

-1.6%-21.4% pts

Net margin

-1.6%-15.9% pts

FCF margin

0.5%-16.3% pts
MetricTTM
2026
2025
2024
2023
Income Statement
Revenue$25.4M$25.4M$83.5M$135.3M$12.5M
Net Income$-400000.00$-400000.00$446000.00$1.5M$1.8M
EBITDA$-366000.00$-366000.00$602000.00$2.3M$2.5M
EPS——0.020.130.16
Gross Margin14.5%14.5%11.4%6.4%29.9%
Operating Margin-1.6%-1.6%0.7%1.7%19.8%
Net Margin-1.6%-1.6%0.5%1.1%14.3%
Balance Sheet
Debt/Equity0.010.010.010.010.01
Cash Flow
Free Cash Flow$123000.00$123000.00$3.0M$-1.2M$2.1M
Returns
ROE-0.1%-0.1%0.1%1.2%1.5%
Valuation
P/E——731.5090.2329.94
EV/EBITDA——545.9058.6721.05
P/B0.290.291.021.080.45
Growth & Yield
Revenue Growth-69.5%-69.5%-38.3%979.0%—
EPS Growth——-84.6%-18.8%—

Revenue, Net Income & Free Cash Flow ($B)

Margins (%)

Returns (%)

Leverage & Liquidity

Reverse DCF · market-implied EPS growthterminal P/E 15.0x · COE 10.0%
Reverse DCF requires positive EPS; loss-making or zero-EPS companies cannot produce a clean EPS hurdle.

Qué te dice: cuánto EPS CAGR está descontando el precio si sales al múltiplo terminal indicado. Si el growth observado queda por debajo, el mercado está pidiendo una ejecución muy fina.

Return attribution · 1Y approxreconcilia total -69.3%

Total return

-69.3%

Start / end P/E

n/dx → n/dx

EPS bridge

0.02 → n/d

Residual

-69.3%

EPS growthn/d
Multiple reratingn/d
Dividend+0.0%
Residual / FX / buybacks / cross-term-69.3%

EPS/multiple decomposition requires positive EPS at both endpoints; residual absorbs price move not explained by dividends.

Simple additive decomposition: total return = EPS growth contribution + P/E multiple contribution + dividend contribution + explicit residual. The residual captures cross-terms, buybacks/share-count effects, FX, special dividends, data noise and methodology mismatch so the bridge always reconciles.